These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28425410)

  • 41. Results of salvage liver transplantation.
    Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F
    Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
    Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
    Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
    Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure?
    De Carlis L; Di Sandro S; Giacomoni A; Mangoni I; Lauterio A; Mihaylov P; Cusumano C; Rampoldi A
    J Clin Gastroenterol; 2013 Apr; 47(4):352-8. PubMed ID: 23188072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis.
    Meyerovich G; Goykhman Y; Nakache R; Nachmany I; Lahat G; Shibolet O; Menachem Y; Katchman H; Wolf I; Geva R; Klausner JM; Lubezky N
    Transplant Proc; 2019; 51(6):1867-1873. PubMed ID: 31399171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma.
    Brahmania M; Ahmed O; Kelley M; Wong D; Kowgier M; Khalili K; Beecroft R; Renner EL; Shah H; Feld J; Janssen HLA; Sherman M
    Ann Hepatol; 2017; 16(5):765-771. PubMed ID: 28809734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
    Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
    Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
    Lei JY; Yan LN; Wang WT
    World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis.
    Lei JY; Wang WT; Yan LN
    World J Gastroenterol; 2013 Sep; 19(36):6077-83. PubMed ID: 24106409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
    Mehta N; Frenette C; Tabrizian P; Hoteit M; Guy J; Parikh N; Ghaziani TT; Dhanasekaran R; Dodge JL; Natarajan B; Holzner ML; Frankul L; Chan W; Fobar A; Florman S; Yao FY
    Gastroenterology; 2021 Nov; 161(5):1502-1512. PubMed ID: 34331914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pretransplant absolute monocyte count in peripheral blood predicts posttransplant tumor prognosis in patients undergoing liver transplantation for hepatocellular carcinoma.
    Kim YK; Kim SH; Lee SD; Lee SA; Park SJ
    Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):250-8. PubMed ID: 24919607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
    Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
    JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.
    Samoylova ML; Dodge JL; Yao FY; Roberts JP
    Liver Transpl; 2014 Aug; 20(8):937-44. PubMed ID: 24797145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation.
    Liu B; Teng F; Fu H; Guo WY; Shi XM; Ni ZJ; Gao XG; Ma J; Fu ZR; Ding GS
    BMC Gastroenterol; 2015 Oct; 15():138. PubMed ID: 26472203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
    de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
    Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wait and transplant for stage 2 hepatocellular carcinoma with deceased-donor liver grafts.
    Chan SC; Sharr WW; Chok KS; Chan AC; Lo CM
    Transplantation; 2013 Dec; 96(11):995-9. PubMed ID: 23924774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.
    Piñero F; Costa P; Boteon YL; Duque SH; Marciano S; Anders M; Varón A; Zerega A; Poniachik J; Soza A; Machaca MP; Menéndez J; Zapata R; Vilatoba M; Muñoz L; Maraschio M; Fauda M; McCormack L; Gadano A; Boin IS; García JHP; Silva M
    Ann Hepatol; 2018 Mar; 17(2):256-267. PubMed ID: 29469048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patient.
    Nissen NN; Menon V; Bresee C; Tran TT; Annamalai A; Poordad F; Fair JH; Klein AS; Boland B; Colquhoun SD
    HPB (Oxford); 2011 Sep; 13(9):626-32. PubMed ID: 21843263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
    Gutin L; Yao F; Dodge JL; Grab J; Mehta N
    JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of liver transplantation for hepatocellular carcinoma -- a single center experience.
    Iacob R; Iacob S; Gheorghe L; Gheorghe C; Hrehoreţ D; Brașoveanu V; Croitoru A; Herlea V; Popescu I
    Chirurgia (Bucur); 2013; 108(4):446-50. PubMed ID: 23958083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.